52 Week Lows

Endologix, Inc. (NASDAQ: ELGX) shares fell 10.7 percent to touch a new 52-week low of $6.15 as the company disclosed that it has received suspension of CE Mark for AFX System. Aradigm Corporation (NASDAQ: ARDM) shares reached a new 52-week low of $1.90. Aradigm shares have dropped 45.14...

Line Corp (ADR) (NYSE: LN) shares touched a new 52-week low of $35.20. Galena Biopharma Inc (NASDAQ: GALE) shares reached a new 52-week low of $2.35. Galena Biopharma shares have climbed 61.74 percent over the past 52 weeks, while the S&P 500 index has gained 11.75 percent in the same...

DavidsTea Inc (NASDAQ: DTEA) shares dropped 19 percent to touch a new 52-week low of $7.55. DavidsTea reported a Q3 loss of C$0.10 per share on revenue of C$44.1 million. BMO Capital downgraded DavidsTea from Outperform to Market Perform. Atlantic Alliance Partnership Corp (NASDAQ: AAPC)...

Oncomed Pharmaceuticals Inc (NASDAQ: OMED) shares dropped 5.3 percent to touch a new 52-week low of $7.72. Oncomed Pharmaceuticals shares have dropped 60.72 percent over the past 52 weeks, while the S&P 500 index has gained 8.61 percent in the same period. Gilead Sciences, Inc. (NASDAQ...

Applied DNA Sciences Inc (NASDAQ: APDN) shares touched a new 52-week low of $1.775. Applied DNA Sciences reported a Q4 loss of $2.4 million on revenue of $1.6 million. Illumina, Inc. (NASDAQ: ILMN) shares touched a new 52-week low of $120.25. Illumina named Sam A. Samad as its Chief Financial...

  Juno Therapeutics Inc (NASDAQ: JUNO) shares fell 6.3 percent to touch a new 52-week low of $19.14. Raymond James downgraded Juno Therapeutics from Outperform to Market Perform. PDL BioPharma Inc (NASDAQ: PDLI) shares touched a new 52-week low of $2.03. PDL BioPharma shares have...

  Cerecor Inc (NASDAQ: CERC) shares fell 26.7 percent to touch a new 52-week low of $1.28 after the company disclosed that its CERC-501 Phase 2 study did not meet primary objective. FirstEnergy Corp. (NYSE: FE) shares touched a new 52-week low of $30.245. FirstEnergy shares have...

  Medigus Ltd. - American Depositary Share (NASDAQ: MDGS) shares touched a new 52-week low of $0.621. On Thursday, Medigus announced 1.1 million share direct offering at $0.67 per ADS. Under Armour Inc (NYSE: UA) shares fell 2.8 percent to reach a new 52-week low of $29.63. Under...

  Express, Inc. (NYSE: EXPR) shares fell 19.3 percent to touch a new 52-week low of $10.78 after the company issued a weak outlook for the fourth quarter. The Coca-Cola Co (NYSE: KO) shares reached a new 52-week low of $39.96. Coca-Cola shares have dropped 5.92 percent over the past...

  Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) shares fell 61.5 percent to touch a new 52-week low of $1.69 after the company announced it was discontinuing all its clinical RNAi programs. The company also announced plans to reduce workforce by 30 percent. Galena Biopharma Inc (NASDAQ...

  PDL BioPharma Inc (NASDAQ: PDLI) shares fell 3.5 percent to touch a new 52-week low of $2.32. PDL BioPharma shares have declined 36.68 percent over the past 52 weeks, while the S&P 500 index has gained 5.83 percent in the same period. Nivalis Therapeutics Inc (NASDAQ: NVLS)...

  Towerstream Corporation (NASDAQ: TWER) shares fell 12.7 percent to reach a new 52-week low of $0.382. Towerstream shares have dropped 94.66 percent over the past 52 weeks, while the S&P 500 index has increased 6.39 percent in the same period. iKang Healthcare Group Inc (ADR) (...

  Neurometrix Inc (NASDAQ: NURO) shares reached a new 52-week low of $1.11. Neurometrix shares have dropped 57.97 percent over the past 52 weeks, while the S&P 500 index has increased 5.55 percent in the same period. Towerstream Corporation (NASDAQ: TWER) shares fell 9.4 percent...

  Juno Therapeutics Inc (NASDAQ: JUNO) shares reached a new 52-week low of $20.45 as the company disclosed that it has placed JCAR015 Phase II ROCKET trial on clinical hold after 2 patients suffered cerebral edema earlier this week. BioDelivery Sciences International, Inc. (NASDAQ:...

  Patterson Companies, Inc. (NASDAQ: PDCO) shares reached a new 52-week low of $37.92 on downbeat Q2 results. RiceBran Technologies (NASDAQ: RIBT) shares touched a new 52-week low of $0.990. RiceBran Technologies shares have declined 40.91 percent over the past 52 weeks, while the S...